Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 2-?[(2E)?-?3,?7-?dimethyl-?2,?6-?octadien-?1-?yl]?-?5,?6-?dimethoxy-?3-?methyl-2,?5-?cyclohexadiene-?1,?4-?dione
- Correlated keywords
- 7704-04-3 precursor CoQ10 Q-10 Q-2 Co-Q isoprenoid co-enzyme BALL1 Huh-7 Hep-G2 HepG-2
- Product Overview:
Coenzyme Q10 (Item No. 11506) is a component of the electron transport chain and participates in aerobic cellular respiration, generating energy in the form of ATP.{20670} In its reduced form, it acts as an antioxidant.{20670} Coenzyme Q2 (CoQ2) is a biosynthetic precursor to the electron transport chain cofactor CoQ10 (Item No. 11506) and an inhibitor of mitochondrial complex I, also known as NADH dehydrogenase.{30591,24936} It is an electron acceptor that accepts electrons from mitochondrial complex I. CoQ2 inhibits the proliferation of BALL-1 human B cell acute lymphoblastic leukemia cells (IC50 = 20 µM) and induces apoptosis in Huh7 and HepG2 hepatoma cells when used at a concentration of 100 µM.{30186} It increases the production of reactive oxygen species (ROS) in BALL-1 cells but inhibits ROS production in mitochondrial membranes derived from bovine heart when used in combination with the mitochondrial complex I inhibitors rotenone (Item No. 13995), piericidin A (Item No. 15379), or rolliniastatin 1 or -2.{30186,24936} CoQ2 increases the production of hydrogen peroxide in isolated rabbit heart mitochondria and decreases it in isolated rabbit liver mitochondria.{66215}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.